Enhanced immunogenicity of the tuberculosis subunit Rv0572c vaccine delivered in DMT liposome adjuvant as a BCG-booster
- 26 February 2022
- journal article
- research article
- Published by Elsevier in Tuberculosis
- Vol. 134, 102186
Abstract
No abstract availableKeywords
Funding Information
- Anhui University of Science and Technology
This publication has 51 references indexed in Scilit:
- Syk Kinase-Coupled C-type Lectin Receptors Engage Protein Kinase C-δ to Elicit Card9 Adaptor-Mediated Innate ImmunityImmunity, 2012
- Understanding Latent Tuberculosis: A Moving TargetThe Journal of Immunology, 2010
- Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin MincleJournal of Experimental Medicine, 2009
- Cell-Mediated Immune Responses in TuberculosisAnnual Review of Immunology, 2009
- Pattern recognition receptors and control of adaptive immunityImmunological Reviews, 2008
- Nanotechnology in vaccine deliveryAdvanced Drug Delivery Reviews, 2008
- Lack of Immune Responses to Mycobacterium tuberculosis DosR Regulon Proteins following Mycobacterium bovis BCG VaccinationInfection and Immunity, 2007
- Next generation: tuberculosis vaccines that elicit protective CD8+T cellsExpert Review of Vaccines, 2007
- Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients.Journal of Experimental Medicine, 1983
- Importance of thymus-derived lymphocytes in cell-mediated immunity to infectionCellular Immunology, 1973